A study on glial cancer has shown that IGHG1 can play an interfering role in the immune system’s fight against cancer cells, thus inducing immune escape of cancer cells, making the expression of IGHG1 negatively correlated with the survival rate of patients and their prognosis [51,53]. The gene discussed is IGHG1; the disease is cancer.